PoliticalRepoPoliticalRepo

Germany · Question · Mündliche Frage

20/11579

Medicines for long and post-COVID patients

openGermany· German Bundestag· DE

Introduced

31 May 2024

Last action

5 June 2024 · Mündliche Frage/Schriftliche Antwort

Status

Beantwortet

Sponsors

Subjects

Discovery layer

Source updated

13 January 2026

Summary

Original text of the question(s):<br /> <br /> What is the current status regarding the list of medications to be drawn up by the “Long COVID Off-Label Use” expert group that can be prescribed and paid for for long and post-COVID patients even outside of the approval, or how does the federal government assess this?

Machine translation from German. The official text remains authoritative.

Timeline

  1. 31 May 2024

    Mündliche Frage

    Medicines for long and post-COVID patients

    Source: BT

  2. 5 June 2024

    Mündliche Frage/Schriftliche Antwort

    Medicines for long and post-COVID patients

    Source: BT

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.